Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Voyager Therapeutics, Inc. Income Statement Banner

Voyager Therapeutics, Inc. Income Statement

VYGR Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.00017.334M14.220M10.135M7.619M104.391M171.128M37.415M40.907M250.008M
Cost of Revenue
8.898M27.679M42.249M62.260M64.905M119.735M108.753M73.787M6.191M92.172M
Gross Profit
-8.898m-10.345m-28.029m-52.125m-57.286m-15.344m62.375M-36.372m34.716M157.836M
Operating Expense
14.367M37.588M55.519M81.998M98.714M156.070M143.744M111.033M91.744M35.822M
Operating Income
-14.367m-20.254m-41.299m-71.863m-91.095m-51.679m27.384M-73.618m-50.837m122.014M
Other Income Expense
0.000-9.418m1.158M1.165M2.627M8.082M7.698M2.421M4.445M-92.172m
Total Other Income Expense
-1.950m-9.418m1.158M1.165M2.627M8.082M9.357M2.421M4.445M11.724M
Pretax Income
-16.317m-29.672m-40.141m-70.698m-88.468m-43.597m36.741M-71.197m-46.392m133.738M
Tax Provision
0.000-600.000k52.000K-1.595m-180.000k-2.765m-1.659m-5.165m16.000K1.408M
Net Income
-16.317m-29.672m-40.193m-70.698m-88.288m-40.832m36.741M-66.032m-46.408m132.330M
Basic EPS
-1.110-7.080-1.590-2.640-2.750-1.1400.990-1.750-1.2103.080
Diluted EPS
-1.110-7.080-1.590-2.640-2.750-1.1400.980-1.750-1.2102.970
Basic Average Shares
14.713M4.191M25.302M26.804M32.066M35.898M37.132M37.669M38.357M43.021M
Diluted Average Shares
14.713M4.191M25.302M26.804M32.066M35.898M37.349M37.669M38.357M44.569M
Total Expenses
14.367M37.588M55.519M81.998M98.714M156.070M143.744M111.033M91.744M127.994M
Interest Income
0.0000.0000.0001.227M0.0006.457M1.659M390.000K1.792M11.721M
Interest Expense
0.000332.000K976.000K0.0000.0000.0000.0000.0001.792M0.000
EBITDA
-14.183m-19.654m-40.687m-70.268m-88.978m-48.914m31.201M-68.453m-44.646m126.455M
Depreciation & Amortization
184.000K600.000K612.000K1.595M2.117M2.765M3.817M5.165M6.191M4.441M